Myriad Genetics, Inc. MYGN

Full chart Compare
Set alert

Price alert · MYGN

All alert types
6.02 USD -0.02 (-0.33%)

At closeNov 4, 2026, 6:30 PM EST

6.70 +0.68 +11.30%

After hours · Nov 4, 6:30 PM ET

5.90 Day range 6.20
2.74 52-week range 8.09
YTD
-2.11%
1 year
-6.81%

Financial health

Altman Z-Score

-0.87 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

2 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

C-1 / 5 overall

  • DCF 1
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 1
  • P/E 1
  • P/B 4

Valuation

P/E -1.6×
FY 2016: 80.8×FY 2017: 19.8×FY 2018: 439×FY 2019: -4.2×FY 2020: -6.6×FY 2021: -78.9×FY 2022: -10.4×FY 2023: -6.0×FY 2024: -9.7×FY 2025: -1.6×
FY 2016 5y median -9.7× FY 2025
P/S 0.7×
FY 2016: 2.4×FY 2017: 3.5×FY 2018: 2.4×FY 2019: 1.3×FY 2020: 2.7×FY 2021: 3.1×FY 2022: 1.7×FY 2023: 2.1×FY 2024: 1.5×FY 2025: 0.7×
FY 2016 5y median 1.7× FY 2025
P/B 1.6×
FY 2016: 2.3×FY 2017: 2.7×FY 2018: 1.9×FY 2019: 0.9×FY 2020: 1.7×FY 2021: 2.2×FY 2022: 1.3×FY 2023: 2.0×FY 2024: 1.8×FY 2025: 1.6×
FY 2016 5y median 1.8× FY 2025
P/FCF -22.4×
FY 2016: 17.6×FY 2017: 24.1×FY 2018: 26.9×FY 2019: 16.7×FY 2020: -36.8×FY 2021: 3575×FY 2022: -7.7×FY 2023: -8.6×FY 2024: -32.3×FY 2025: -22.4×
FY 2016 5y median -8.6× FY 2025
EV/EBITDA -1.9×
FY 2016: 19.5×FY 2017: 14.0×FY 2018: 25.4×FY 2019: -6.9×FY 2020: -13.4×FY 2021: 161×FY 2022: -14.8×FY 2023: -8.1×FY 2024: -21.5×FY 2025: -1.9×
FY 2016 5y median -8.1× FY 2025
EV/Sales 0.8×
FY 2016: 2.4×FY 2017: 3.4×FY 2018: 2.5×FY 2019: 1.5×FY 2020: 3.0×FY 2021: 2.9×FY 2022: 1.9×FY 2023: 2.1×FY 2024: 1.5×FY 2025: 0.8×
FY 2016 5y median 1.9× FY 2025
FCF Yield -4.5%
FY 2016: 5.7%FY 2017: 4.1%FY 2018: 3.7%FY 2019: 6.0%FY 2020: -2.7%FY 2021: 0.0%FY 2022: -13.0%FY 2023: -11.6%FY 2024: -3.1%FY 2025: -4.5%
FY 2016 5y median -4.5% FY 2025

Profitability

Gross Margin 69.9%
FY 2016: 76.5%FY 2017: 76.2%FY 2018: 76.4%FY 2019: 70.9%FY 2020: 68.0%FY 2021: 71.4%FY 2022: 70.2%FY 2023: 68.6%FY 2024: 69.9%FY 2025: 69.9%
FY 2016 5y median 69.9% FY 2025
Operating Margin -8.2%
FY 2016: 6.0%FY 2017: 16.4%FY 2018: 0.9%FY 2019: -36.3%FY 2020: -35.0%FY 2021: -27.6%FY 2022: -18.2%FY 2023: -19.2%FY 2024: -10.5%FY 2025: -8.2%
FY 2016 5y median -18.2% FY 2025
Net Margin -44.4%
FY 2016: 2.4%FY 2017: 17.9%FY 2018: 0.5%FY 2019: -31.2%FY 2020: -40.2%FY 2021: -3.9%FY 2022: -16.5%FY 2023: -35.0%FY 2024: -15.2%FY 2025: -44.4%
FY 2016 5y median -16.5% FY 2025
ROE -99.4%
FY 2016: 2.3%FY 2017: 13.8%FY 2018: 0.4%FY 2019: -21.7%FY 2020: -25.4%FY 2021: -2.8%FY 2022: -12.6%FY 2023: -33.6%FY 2024: -18.2%FY 2025: -99.4%
FY 2016 5y median -18.2% FY 2025
ROIC -10.8%
FY 2016: 2.1%FY 2017: 11.4%FY 2018: 0.5%FY 2019: -16.3%FY 2020: -11.9%FY 2021: -8.0%FY 2022: -9.2%FY 2023: -14.4%FY 2024: -10.0%FY 2025: -10.8%
FY 2016 5y median -10.0% FY 2025
ROA -51.8%
FY 2016: 1.4%FY 2017: 11.3%FY 2018: 0.3%FY 2019: -14.2%FY 2020: -15.8%FY 2021: -2.1%FY 2022: -9.3%FY 2023: -23.0%FY 2024: -12.4%FY 2025: -51.8%
FY 2016 5y median -12.4% FY 2025

Growth (YoY)

Revenue -1.6%
FY 2016: -1.6%FY 2017: 2.1%FY 2018: 14.4%FY 2019: -25.0%FY 2020: -12.8%FY 2021: 24.0%FY 2022: -1.8%FY 2023: 11.0%FY 2024: 11.2%FY 2025: -1.6%
FY 2016 FY 2025
Operating Income 23.0%
FY 2016: -71.3%FY 2017: 177.0%FY 2018: -93.8%FY 2019: -3148.7%FY 2020: 15.9%FY 2021: 2.2%FY 2022: 35.1%FY 2023: -16.9%FY 2024: 39.1%FY 2025: 23.0%
FY 2016 FY 2025
EPS (diluted) -180.9%
FY 2016: -81.3%FY 2017: 468.8%FY 2018: -96.7%FY 2019: -4536.2%FY 2020: -11.4%FY 2021: 88.3%FY 2022: -297.1%FY 2023: -128.8%FY 2024: 55.7%FY 2025: -180.9%
FY 2016 FY 2025
Free Cash Flow 33.3%
FY 2016: -37.9%FY 2017: 7.4%FY 2018: -30.1%FY 2019: -32.8%FY 2020: -179.4%FY 2021: 101.5%FY 2022: -25366.7%FY 2023: -21.5%FY 2024: 79.2%FY 2025: 33.3%
FY 2016 FY 2025

Financial Health

Current Ratio 2.5×
FY 2016: 1.4×FY 2017: 3.2×FY 2018: 3.0×FY 2019: 2.3×FY 2020: 2.7×FY 2021: 2.4×FY 2022: 2.0×FY 2023: 2.0×FY 2024: 1.8×FY 2025: 2.5×
FY 2016 5y median 2.0× FY 2025
Quick Ratio 2.3×
FY 2016: 1.2×FY 2017: 2.9×FY 2018: 2.7×FY 2019: 2.1×FY 2020: 2.5×FY 2021: 2.3×FY 2022: 1.9×FY 2023: 1.9×FY 2024: 1.6×FY 2025: 2.3×
FY 2016 5y median 1.9× FY 2025
Debt / Equity 0.6×
FY 2016: 0.1×FY 2017: 0.0×FY 2018: 0.2×FY 2019: 0.3×FY 2020: 0.3×FY 2021: 0.1×FY 2022: 0.2×FY 2023: 0.2×FY 2024: 0.2×FY 2025: 0.6×
FY 2016 5y median 0.2× FY 2025
Net Debt / EBITDA -0.2×
FY 2016: -0.0×FY 2017: -0.6×FY 2018: 1.7×FY 2019: -0.9×FY 2020: -1.4×FY 2021: -13.4×FY 2022: -1.0×FY 2023: -0.1×FY 2024: -0.6×FY 2025: -0.2×
FY 2016 5y median -0.6× FY 2025
Interest Coverage -6.5×
FY 2016: 7.3×FY 2017: 38.1×FY 2018: 0.6×FY 2019: -21.5×FY 2020: 0.0×FY 2021: -28.9×FY 2022: -38.7×FY 2023: -49.9×FY 2024: -31.4×FY 2025: -6.5×
FY 2016 5y median -31.4× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31